{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-009961","form_type":"8-K","ticker":"VOR","cik":"0001817229","company_name":"Vor Biopharma Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.286759+00:00","generated_at":"2026-05-16T10:56:01.403422+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"medium","headline":"Vor Biopharma reports preliminary cash of ~$450M as of Dec 31, 2025","bullets":["Cash, cash equivalents and short-term investments ~$450M as of Dec 31, 2025 (preliminary, unaudited).","Company presenting at 44th Annual J.P. Morgan Healthcare Conference on Jan 13, 2026.","Financial data is subject to change upon completion of audited FY 2025 statements."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-009961","json":"https://secwatch.observer/filing/0001193125-26-009961.json","markdown":"https://secwatch.observer/filing/0001193125-26-009961.md","text":"https://secwatch.observer/filing/0001193125-26-009961.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1817229/000119312526009961/0001193125-26-009961-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1817229/000119312526009961/vor-20260112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:56:01.403422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}